Hyperspectral Imaging Pre and Post Endovascular Intervention
- Conditions
- Chronic Limb IschemiaNon-Healing Ulcers
- Registration Number
- NCT00768495
- Lead Sponsor
- HyperMed
- Brief Summary
This trial will collect tissue oxygenation data via hyperspectral imaging before and after endovascular procedures.
- Detailed Description
This will be a nonrandomized, nonblinded, prospective observational study to correlate the results obtained with the traditional measures of success of endovascular revascularization of peripheral arteries for the treatment of chronic limb ischemia; i.e., ABPI, PVR with oxyhemoglobin (OxyHb) and deoxyhemoglobin (DeoxyHb) measurements obtained with a new imaging device manufactured by HyperMed Inc (OxyVu) that uses hyperspectral technology.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- Patients with established diagnosis of lower limb ischemic based on their symptoms of claudication, rest pain, non-healing ulcers or gangrene and other vascular laboratory tests that are currently used to make this diagnosis and have been scheduled for endovascular revascularization.
- Age group between 50-85
- Gender - Male or Female
- Race - all race and ethnicities
- Patients with known cardiac disease - new MI (within 3 months).
- Patients with hypertension with the systolic BP >200 or diastolic BP>110 on the day of testing
- Patients on supplemental O2 for chronic obstructive lung disease
- Bed-ridden subjects - either due to chronic disability or neurological problems
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cardiac, Vascular & Thoracic Surgery Associates
🇺🇸Falls Church, Virginia, United States